Article is a month+ old and there is nothing new beside the great update about Sabby and others funds.for the first time ever KTOV has real insiders ( about 50% ownership) and be sure they did tbey DD or potential before invested $12m. Cap is only $22m a/o today so close to NDA submission for a drug that could easily bring in few hundred million in revenue annually. Backup w/patent till 2029. A very solid balance sheet, zero debt and trading close to Cash on Hand.
My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.